<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08437023771259</udiDi>
    <basicUdiDi>8437023771SYRUPG26K</basicUdiDi>
    <tradeName>AROMAFORCE JUNIOR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>22884</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.157Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437023771273</udiDi>
    <basicUdiDi>8437023771SYRUPG46P</basicUdiDi>
    <tradeName>AROMAFORCE EXTRA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>22870</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.131Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437023771440</udiDi>
    <basicUdiDi>8437023771SYRUPG26K</basicUdiDi>
    <tradeName>AROMAFORCE JUNIOR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>23277</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.118Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437023771457</udiDi>
    <basicUdiDi>8437023771SYRUPG26K</basicUdiDi>
    <tradeName>AROMAFORCE JUNIOR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>23279</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.103Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437023771464</udiDi>
    <basicUdiDi>8437023771SYRUPG26K</basicUdiDi>
    <tradeName>AROMAFORCE JUNIOR</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>23366</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.089Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437023771471</udiDi>
    <basicUdiDi>8437023771SYRUPG46P</basicUdiDi>
    <tradeName>AROMAFORCE EXTRA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>23270</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.076Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437023771488</udiDi>
    <basicUdiDi>8437023771SYRUPG46P</basicUdiDi>
    <tradeName>AROMAFORCE EXTRA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>23272</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.061Z</lastUpdated>
  </row>
  <row>
    <udiDi>08437023771495</udiDi>
    <basicUdiDi>8437023771SYRUPG46P</basicUdiDi>
    <tradeName>AROMAFORCE EXTRA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>PRANARÔM ESPAÑA S.L.U</manufacturerName>
    <manufacturerSrn>ES-MF-000014215</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>23381</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:35:18.046Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043691042</udiDi>
    <basicUdiDi>B-06430043691042</basicUdiDi>
    <tradeName>Apteq Fluzinc Salmiakki suihke 25 ml</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9288166</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:41.225Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043690946</udiDi>
    <basicUdiDi>B-06430043690946</basicUdiDi>
    <tradeName>Apteq Fluzinc Hunaja 72 tabl.</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9282457</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:40.021Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043690939</udiDi>
    <basicUdiDi>B-06430043690939</basicUdiDi>
    <tradeName>Apteq Fluzinc Hunaja 24 tabl.</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9281929</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:38.823Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043690816</udiDi>
    <basicUdiDi>B-06430043690816</basicUdiDi>
    <tradeName>Apteq Mielikki 200 ml</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9264186</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:36.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043690793</udiDi>
    <basicUdiDi>B-06430043690793</basicUdiDi>
    <tradeName>Apteq Fluzinc Salmiakki 72 tabl.</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9259390</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:35.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043690786</udiDi>
    <basicUdiDi>B-06430043690786</basicUdiDi>
    <tradeName>Apteq Fluzinc Salmiakki 24 tabl.</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9259379</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:34.026Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043690731</udiDi>
    <basicUdiDi>B-06430043690731</basicUdiDi>
    <tradeName>Apteq Fluzinc Mustaherukka 72 tabl.</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9240118</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:32.834Z</lastUpdated>
  </row>
  <row>
    <udiDi>06430043690700</udiDi>
    <basicUdiDi>B-06430043690700</basicUdiDi>
    <tradeName>Apteq Fluzinc Mustaherukka 24 tabl.</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Galena Pharma Oy</manufacturerName>
    <manufacturerSrn>FI-MF-000000588</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>9236114</reference>
    <placedOnMarketCountry>Finland</placedOnMarketCountry>
    <lastUpdated>2026-06-23T07:33:31.642Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000210</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00210</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.953Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000555</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00361</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.936Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000746</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00354</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.921Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855933000777</udiDi>
    <basicUdiDi>855933000ORAPL</basicUdiDi>
    <tradeName>XyliMelts - DACH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Quest Products LLC</manufacturerName>
    <manufacturerSrn>US-MF-000014101</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>V9017</emdnCode>
    <emdnDescription>ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ORA00777</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:23.905Z</lastUpdated>
  </row>
</eudamedExport>